Lv4
452 积分 2021-03-23 加入
A Phase 1 First‐in‐Human Pharmacokinetic and Pharmacodynamic Study of JNJ‐64264681, a Covalent Inhibitor of Bruton's Tyrosine Kinase
1天前
已完结
Of Mice, Whales, Jellyfish and Men: In Pursuit of Increased Longevity
14天前
已完结
Adipokines: masterminds of metabolic inflammation
16天前
已完结
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
1个月前
已完结
A First-in-Human Phase 1/2 Dose-Escalation Study of MAK683 (EED Inhibitor) in Patients with Advanced Malignancies
1个月前
已完结
Kinase-deficient BTK mutants confer ibrutinib resistance through activation of the kinase HCK
1个月前
已完结
Epigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma
1个月前
已完结
New insights into the biology of T-cell lymphomas
1个月前
已完结
Genomic mutation patterns and prognostic value in de novo and secondary acute myeloid leukemia: A multicenter study from China
1个月前
已完结
IDH2 mutations in acute myeloid leukemia
1个月前
已完结
皖公网安备34019202002308
